These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36181724)

  • 1. The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants.
    Williams CL; Fareed R; Mortimer GLM; Aitken RJ; Wilson IV; George G; Gillespie KM; Williams AJK; ; Long AE
    Clin Exp Immunol; 2022 Dec; 210(2):151-162. PubMed ID: 36181724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics.
    Grace SL; Bowden J; Walkey HC; Kaur A; Misra S; Shields BM; McKinley TJ; Oliver NS; McDonald TJ; Johnston DG; Jones AG; Patel KA
    J Clin Endocrinol Metab; 2022 Nov; 107(12):e4341-e4349. PubMed ID: 36073000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional study.
    Fan W; Nan X; Peng Y; Li X; Xiang Y; Yan X; Xie Z; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
    Diabetes Metab Res Rev; 2023 Feb; 39(2):e3592. PubMed ID: 36401613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Mistry S; Gouripeddi R; Raman V; Facelli JC
    Diabetologia; 2023 Mar; 66(3):520-534. PubMed ID: 36446887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages.
    Nan X; Li X; Xiang Y; Yan X; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
    Diabetes Technol Ther; 2022 Mar; 24(3):212-219. PubMed ID: 34704825
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden.
    Törn C; Vaziri-Sani F; Ramelius A; Elding Larsson H; Ivarsson SA; Amoroso M; Furmaniak J; Powell M; Smith BR
    Acta Diabetol; 2022 Jun; 59(6):773-781. PubMed ID: 35220476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children.
    Salami F; Tamura R; You L; Lernmark Å; Larsson HE; Lundgren M; Krischer J; Ziegler AG; Toppari J; Veijola R; Rewers M; Haller MJ; Hagopian W; Akolkar B; Törn C;
    Pediatr Diabetes; 2022 Dec; 23(8):1586-1593. PubMed ID: 36082496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.
    Brorsson CA; Onengut S; Chen WM; Wenzlau J; Yu L; Baker P; Williams AJ; Bingley PJ; Hutton JC; Eisenbarth GS; Concannon P; Rich SS; Pociot F;
    Diabetes; 2015 Aug; 64(8):3017-27. PubMed ID: 25829454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
    Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
    Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.